It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study.
source https://www.sciencedaily.com/releases/2024/10/241017112207.htm
I Tested Grok 3, and It's Not Worth the Price Hike
-
Earlier this week, xAI released Grok 3, the company's most advanced AI yet,
complete with a reasoning model and a DeepSearch feature. The company
claims ...
19 hours ago
Welcome to the 'The Fact Factory' friends. Its an interesting Hot Spot which brings to you amazing and little known facts from all over the world. So, sit back, take a tour around the world and enjoy the trivia.
No comments:
Post a Comment